Sanovas Surgical Technologies Company Profile
Sanovas revolutionary Smart Catheter technologies will now afford doctors the tools to venture into areas of the anatomy where they have never been.
News from Sanovas Surgical Technologies:
Sanovas Awarded Global "Top-50" Start-Up Company
Silicon Valley's "TiE50" Award Hotly Contested by Thousands of Technology Startups Worldwide SAN RAFAEL, Calif., May 28, 2015 /PRNewswire/ — Sanovas, Inc., a rapidly growing life science company, has been recognized as one of the Top 50 Start-Up Companies in the World at the Silicon Valley TiE50 Award ceremony. Logo – http://photos.prnewswire.com/prnh/20150528/219097LOGO TiE's carefully chosen panel of […]
Mandate would preclude reprocessors from having to rely solely on the naked eye to inspect hard-to-clean reusable medical devices SAN RAFAEL, Calif., April 6, 2015 /PRNewswire/ — Sanovas announced today, in the wake of recent headlines about cross contamination of patients by inadequately reprocessed medical devices, that the medical device industry should be including "aided visual inspection" […]
The U.S. healthcare system is about to be deluged with diagnoses of early-stage lung cancers. SAN RAFAEL, Calif., Feb. 10, 2015 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation micro invasive diagnostics, devices and drug delivery technologies, announced today that one of its clinical advisers is warning that the […]
SAN RAFAEL, Calif., Jan. 26, 2015 /PRNewswire/ — In wake of recent headlines about cross contamination of patients by inadequately reprocessed medical devices (see story in USA Today), Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that its MicroCam Inc. subsidiary […]
"The U.S. healthcare system is about to be deluged with diagnoses of early-stage lung cancers, and therefore we need to develop appropriate therapies for peripheral tumors, where the majority of lung cancers begin," said Gordon H. Downie, MD, PhD. SAN RAFAEL, Calif., Jan. 7, 2015 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development […]
Sanovas Receives Frost & Sullivan Award for Breakthrough Endoscopic Imaging Platform, MicroCam™
Frost & Sullivan says, 'The MicroCam platform possesses the potential not only to redefine the economics of endoscopy in North America, but also to expand access to minimally invasive surgery for billions of patients globally.' SAN RAFAEL, Calif., Dec. 1, 2014 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of […]
Sanovas Awarded Seminal Patent for Novel Radiation Oncology Drug/Device Platform
SAN RAFAEL, Calif., Oct. 14, 2014 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation microinvasive diagnostics, devices and drug delivery technologies, announced today that US Patent No. 8,834,544 has issued to the Company. Photo – http://photos.prnewswire.com/prnh/20141013/151744 Logo – http://photos.prnewswire.com/prnh/20141013/151743LOGO The patent, entitled "Photodynamic Therapy for Tumors with Localized Delivery," […]
Flexible Inspection Scope is initial product of Healthmark's OEM partnership with MicroCam, Inc. SAN RAFAEL, Calif., Sept. 22, 2014 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that its MicroCam Inc. subsidiary has commenced commercialization of the MicroCam™ System via […]
SAN RAFAEL, Calif., May 27, 2014 /PRNewswire/ — Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that its MicroCam Inc. subsidiary has signed partnership agreements with two major original equipment manufacturers (OEMs): Healthmark Industries Co. and TeDan Surgical Innovations. Photo – http://photos.prnewswire.com/prnh/20140523/91037 […]
Sanovas Expands Management Team
SAUSALITO, Calif., April 28, 2014 /PRNewswire/ — Sanovas Inc. (www.sanovas.com), a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has appointed five experienced executives to its management team: Ray Gamini (Sun Microsystems, Cisco Systems), Vice President of Finance; Roy Morgan (Abbott Laboratories, NIPRO Diabetes Systems, […]
SAUSALITO, Calif., April 22, 2014 /PRNewswire/ — Sanovas Inc. (www.sanovas.com), a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it is relocating its business operations next month to a 29,000-sq.-ft. 'BioTech Ready' facility at 2593 Kerner Blvd., San Rafael, Calif. The relocation is necessary to accommodate the […]
SAUSALITO, Calif., April 18, 2014 /PRNewswire/ — Sanovas Inc. (www.sanovas.com), a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has been awarded U.S. Patent No. 8,696,621 for its Resector Balloon System for removing undesirable biological material, such as tumors, within bodily cavities without using a shaving […]
Sanovas Appoints Jeff Heer As Chief Operating Officer
SAUSALITO, Calif., April 14, 2014 /PRNewswire/ — Sanovas Inc., a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has appointed Jeff Heer to serve as Chief Operating Officer. Previously, Jeff was Vice President of Manufacturing and Customer Support at Picarro Inc., a leading provider of […]
Sanovas CEO Larry Gerrans Featured at BayBio's 'Fundraising in Troubled Times'
SAUSALITO, Calif., Jan. 24, 2012 — Sanovas CEO Larry Gerrans will participate in a panel titled "Fundraising in Troubled Times" as part of BayBio's Life Sciences Series on Thursday, Jan. 26 at 8 a.m. in Palo Alto. The event will take place at the Silicon Valley offices of DLA Piper. Gerrans will speak about alternative […]
Profiles with Terry Bradshaw to Feature Sanovas
CORAL SPRINGS, Fla., Nov. 21, 2011 — The Producers of Profiles with Terry Bradshaw are pleased to announce that Sanovas will be featured in an upcoming segment on topics, trends, and issues related to "Improving Clinical Outcomes through Technology" as part of the show's "Medical Minutes" series. Lung cancer is the most common form of […]
Sanovas CEO Larry Gerrans Featured Speaker at AdvaMed 2011
Industry's leading medical device visionaries to highlight practical insights and key learnings at AdvaMed 2011 Entrepreneurship Boot Camp SAUSALITO, Calif., Sept. 22, 2011 — Sanovas Inc., a leading developer of minimally invasive technologies for the diagnosis and treatment of pulmonary disease and lung cancer, today announced that CEO and co-founder Larry Gerrans will speak at […]
Science, Government and Industry Converge in National Call to Action on Lung Cancer
SAUSALITO, Calif., Aug. 11, 2011 — The New England Journal of Medicine's recent publication of the landmark National Lung Screening Trial (NLST), along with two congressional initiatives and an industry report, beacon a much brighter future for Lung Cancer patients. Forty-three million Americans suffer from a chronic pulmonary disease, such as Lung Cancer, COPD, Asthma […]
